Search

everythinglearnresearchcommunity

for

Search:↓

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Pranlukast and mirabegron may work as new diabetes drugs.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

Upadacitinib effectively treats pyoderma gangrenosum.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Finasteride increases CD8+ T cells in BPH tissues.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

PLA2R1 overexpression harms kidney cells by stopping their growth cycle.

A blood pressure drug, diltiazem, may also help treat influenza.

Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.

Linagliptin may cause hair loss and skin blisters.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Baricitinib may effectively treat oral lichen planus.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.